Glenmede Trust’s NASPERS LTD NPSN Stock Holding History

Glenmede Trust’s Portfolio NPSN Stock Details NPSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-5,030	Closed	-$86K	–	2997
2017 Q2	$86K	Hold	5,030	–	–	﹤0.01%	1425
2017 Q1	$86K	Buy	5,030 +1,410	+39%	+$24.1K	﹤0.01%	1425
2016 Q4	$53K	Hold	3,620	–	–	﹤0.01%	1592
2016 Q3	$62K	Sell	3,620 -310	-8%	-$5.31K	﹤0.01%	1550
2016 Q2	$59K	Buy	3,930 +1,700	+76%	+$25.5K	﹤0.01%	1521
2016 Q1	$30K	Buy	2,230 +2,007	+900%	+$27K	﹤0.01%	1689
2015 Q4	$30K	Hold	223	–	–	﹤0.01%	1743
2015 Q3	$27K	Hold	223	–	–	﹤0.01%	1799
2015 Q2	$33K	Buy	223 +63	+39%	+$9.32K	﹤0.01%	1758
2015 Q1	$24K	Hold	160	–	–	﹤0.01%	1897
2014 Q4	$20K	Buy	+160	New	+$20K	﹤0.01%	2028

Glenmede Trust's NPSN Position: Q3 2017 in Review

Glenmede Trust sold out of NASPERS LTD (NPSN) in Q3 2017, closing a stake of 5,030 shares — an estimated $86K sold.

Glenmede Trust first reported a position in NPSN in Q4 2014 and held it in 11 quarters. The position peaked at $86K in Q2 2017. 0 funds tracked by Wall St. Rank hold NPSN as of Q3 2017.

Glenmede Trust reported no remaining NASPERS LTD position as of Q3 2017 after selling out during the quarter.
Glenmede Trust sold 5,030 NASPERS LTD shares in Q3 2017, an estimated $86K.
Glenmede Trust first reported a position in NASPERS LTD in Q4 2014 and held it in 11 quarters.
Glenmede Trust's NASPERS LTD position peaked at $86K in Q2 2017.
0 funds tracked by Wall St. Rank held NASPERS LTD as of Q3 2017.

Based on Glenmede Trust's 13F filing for Q3 2017, filed 14 Nov 2017.